Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The Phase 2 False Start

<< Previous

Bullboard Posts

Next >>

Comment by Casperinon Dec 11, 2020 5:59pm

210 Views

Post# 32091229

RE:RE:The Phase 2 False Start

fast track approvals arenot given to any Tom,dic or Harry pharma co. We have recieved 1though read between lines folks exciting times lie ahead if trials show great potential which is w why we are all here in the first place 5 maybe 10 maybe 100 bagger is in order may we all be so lucky with great risk comes great reward $$$$$$$$$$SOMETIMES us small retailers win among the 1%'rs glta boooooooo!!!!!!! $$$$$$$

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments